Early antithrombotic therapy improves 90-day functional outcomes in patients with postinterventional cerebral hyperdensity after mechanical thrombectomy: a retrospective cohort study
5 affiliations
- 1Department of Neurology, Minhang Hospital, Fudan University
- 2Department of Neurology, Huashan Hospital, Fudan University
- 3Shanghai Sixth People's Hospital, Shanghai Jiao Tong University
- 4Human Phenome Institute, Fudan University
- 5Department of Pharmacy, Minhang Hospital, Fudan University
Abstract
Background and purpose: Postinterventional cerebral hyperdensity (PCHD) is a specific type of hyperdensity commonly observed on computed tomography (CT) scans of the head after mechanical thrombectomy (MT). This study aimed to investigate the association between early antithrombotic therapy (EAT) and 90-day functional outcomes in anterior circulation acute ischemic stroke (acAIS) patients with PCHD.
Methods: A retrospective cohort study was conducted on 141 consecutive acAIS patients with PCHD after MT. EAT was defined as antithrombotic therapy administered within 24 h post-MT. The primary outcome was a favorable 90-day functional outcome (modified Rankin Scale (mRS) score of 0–2). The secondary outcomes included 90-day mortality, ΔmRS (defined as the mRS score before MT minus the 90-day mRS score), enlargement of cerebral hyperdensity, and persistent hyperdensity on the 24-h follow-up CT graded by the European Cooperative Acute Stroke Study (ECASS III) morphology. Baseline and outcome data were compared between the EAT and non-EAT groups. Univariate and multivariate logistic regression analyses were performed to assess the association between EAT and favorable outcomes. Sensitivity and subgroup analyses were performed to evaluate the robustness and internal consistency of the results.
Results: Of the 129 patients with complete 90-day mRS data, 59 (45.7%) received EAT. The EAT group had a higher proportion of favorable outcomes (59.3% vs. 37.1%, p = 0.019). A multivariate logistic regression analysis showed that EAT remained significantly associated with favorable outcomes (Model 1: odds ratio (OR) 2.469, 95% confidence interval (CI) 1.195–5.104, p = 0.015; Model 2: OR 2.72, 95% CI 1.02–7.20, p = 0.045; Model 3: OR 3.68, 95% CI 1.32–10.30, p = 0.013), and the results were consistent after imputation based on discharge data and multiple imputation. Sensitivity and subgroup analyses showed consistent results, with no significant interaction effects observed.
Conclusion: EAT is associated with improved 90-day functional outcomes in acAIS patients with PCHD, warranting further investigation in larger prospective studies.
Related
- Thrombophilic Variants and Clinical Outcomes in Young Ischaemic Stroke Patients Undergoing Mechanical Thrombectomy: A Retrospective Cohort Study
- [Clinical characteristics and in-hospital outcomes of patients receiving antithrombotic therapy in a cardiac intensive care unit in sub-Saharan Africa: a retrospective comparative study at the Cardiology Institute of Abidjan].
- Association Between Hypoperfusion Intensity Ratio and Outcomes After Endovascular Thrombectomy in Posterior Circulation Stroke: A Retrospective Study
- Eosinophils, malignant brain edema, and functional outcome after mechanical thrombectomy: a mediation analysis.
- AngioJet rheolytic thrombectomy under superior vena cava filter protection for acute upper extremity deep vein thrombosis in patients with cancer: a single-center, retrospective analysis
BibTeX
@article{luo2026early,
title = {{Early antithrombotic therapy improves 90-day functional outcomes in patients with postinterventional cerebral hyperdensity after mechanical thrombectomy: a retrospective cohort study}},
author = {Yunhe Luo and Jiang Zhao and Ligang Huang and Shiliang Xia and Shidong Wei and Ting Ni and Wenjie Cao and Chunying Shen and Jin Zheng},
journal = {Frontiers in Neurology},
year = {2026},
month = oct,
doi = {10.3389/fneur.2026.1891162},
url = {https://www.frontiersin.org/articles/10.3389/fneur.2026.1891162/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Early antithrombotic therapy improves 90-day functional outcomes in patients with postinterventional cerebral hyperdensity after mechanical thrombectomy: a retrospective cohort study
AU - Yunhe Luo
AU - Jiang Zhao
AU - Ligang Huang
AU - Shiliang Xia
AU - Shidong Wei
AU - Ting Ni
AU - Wenjie Cao
AU - Chunying Shen
AU - Jin Zheng
PY - 2026
DA - 2026/10/23
JO - Frontiers in Neurology
DO - 10.3389/fneur.2026.1891162
UR - https://www.frontiersin.org/articles/10.3389/fneur.2026.1891162/full
AB - Background and purpose: Postinterventional cerebral hyperdensity (PCHD) is a specific type of hyperdensity commonly observed on computed tomography (CT) scans of the head after mechanical thrombectomy (MT). This study aimed to investigate the association between early antithrombotic therapy (EAT) and 90-day functional outcomes in anterior circulation acute ischemic stroke (acAIS) patients with PCHD. Methods: A retrospective cohort study was conducted on 141 consecutive acAIS patients with PCHD after MT. EAT was defined as antithrombotic therapy administered within 24 h post-MT. The primary outcome was a favorable 90-day functional outcome (modified Rankin Scale (mRS) score of 0–2). The secondary outcomes included 90-day mortality, ΔmRS (defined as the mRS score before MT minus the 90-day mRS score), enlargement of cerebral hyperdensity, and persistent hyperdensity on the 24-h follow-up CT graded by the European Cooperative Acute Stroke Study (ECASS III) morphology. Baseline and outcome data were compared between the EAT and non-EAT groups. Univariate and multivariate logistic regression analyses were performed to assess the association between EAT and favorable outcomes. Sensitivity and subgroup analyses were performed to evaluate the robustness and internal consistency of the results. Results: Of the 129 patients with complete 90-day mRS data, 59 (45.7%) received EAT. The EAT group had a higher proportion of favorable outcomes (59.3% vs. 37.1%, p = 0.019). A multivariate logistic regression analysis showed that EAT remained significantly associated with favorable outcomes (Model 1: odds ratio (OR) 2.469, 95% confidence interval (CI) 1.195–5.104, p = 0.015; Model 2: OR 2.72, 95% CI 1.02–7.20, p = 0.045; Model 3: OR 3.68, 95% CI 1.32–10.30, p = 0.013), and the results were consistent after imputation based on discharge data and multiple imputation. Sensitivity and subgroup analyses showed consistent results, with no significant interaction effects observed. Conclusion: EAT is associated with improved 90-day functional outcomes in acAIS patients with PCHD, warranting further investigation in larger prospective studies.
SN - 1664-2295
ER -